| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acid-sensing ion channels as potential therapeutic targets
|
Heusser, Stephanie A.
|
|
|
42 |
12 |
p. 1035-1050
|
artikel
|
| 2 |
Advisory Board and Contents
|
|
|
|
42 |
12 |
p. i-ii
|
artikel
|
| 3 |
Apart, together: reflections on the COVID-19 pandemic
|
Madukwe, Jerry
|
|
|
42 |
12 |
p. 973-975
|
artikel
|
| 4 |
Assembling the P450 puzzle: on the sources of nonadditivity in drug metabolism
|
Davydov, Dmitri R.
|
|
|
42 |
12 |
p. 988-997
|
artikel
|
| 5 |
Cholesterol – the devil you know; ceramide – the devil you don’t
|
Tippetts, Trevor S.
|
|
|
42 |
12 |
p. 1082-1095
|
artikel
|
| 6 |
Engineered antibody fusion proteins for targeted disease therapy
|
Silver, Aliyah B.
|
|
|
42 |
12 |
p. 1064-1081
|
artikel
|
| 7 |
Gut microbiome-oriented therapy for metabolic diseases: challenges and opportunities towards clinical translation
|
Zhang, Xueli
|
|
|
42 |
12 |
p. 984-987
|
artikel
|
| 8 |
Paving the way for designing drugs targeting TMEM16A
|
Pifferi, Simone
|
|
|
42 |
12 |
p. 979-980
|
artikel
|
| 9 |
Pharmacological tools to target NKCC1 in brain disorders
|
Savardi, Annalisa
|
|
|
42 |
12 |
p. 1009-1034
|
artikel
|
| 10 |
Promoting spliceosome assembly for therapeutic intent
|
Lu, Bin
|
|
|
42 |
12 |
p. 981-983
|
artikel
|
| 11 |
PUS7: a targetable epitranscriptomic regulator of glioblastoma growth
|
Zhang, Daniel Y.
|
|
|
42 |
12 |
p. 976-978
|
artikel
|
| 12 |
Safety of medicines and vaccines – building next generation capability
|
Bate, Andrew
|
|
|
42 |
12 |
p. 1051-1063
|
artikel
|
| 13 |
Subscription and Copyright Information
|
|
|
|
42 |
12 |
p. e1
|
artikel
|
| 14 |
Targeting sialylation to treat central nervous system diseases
|
Lünemann, Jan D.
|
|
|
42 |
12 |
p. 998-1008
|
artikel
|
Tijdschrift beschrijving